Cargando…

Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review

OBJECTIVE: Along with the development of novel migraine therapies as the monoclonal antibodies against calcitonin gene‐related peptide (CGRP) and its receptor, the question arises if the treatment of chronic migraine (CM) and medication overuse headache (MOH) must be reconsidered. Have previous ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaltseis, Katharina, Hamann, Till, Gaul, Charly, Broessner, Gregor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100419/ https://www.ncbi.nlm.nih.gov/pubmed/36437611 http://dx.doi.org/10.1111/head.14415

Ejemplares similares

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache
por: Gaul, Charly, et al.
Publicado: (2011)

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
por: Straube, Andreas, et al.
Publicado: (2023)

Brain-derived neurotrophic factor in primary headaches
por: Fischer, Marlene, et al.
Publicado: (2012)

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
por: Cevoli, Sabina, et al.
Publicado: (2017)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1)
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
por: Limberg, Nicole
Publicado: (2023)

CGRP in Primary Headaches
por: Edvinsson, Lars
Publicado: (2001)

Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge
por: Frank, Florian, et al.
Publicado: (2022)

Medication-overuse headache: citalopram associated with analgesics withdrawal as possible treatment
por: Moretti, Rita, et al.
Publicado: (2003)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
por: Genizi, Jacob, et al.
Publicado: (2023)

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
por: Ashina, Håkan, et al.
Publicado: (2022)

Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache
por: Trucco, M., et al.
Publicado: (2005)

Headache impact and socioeconomic status: findings from a study of the German Migraine and Headache Society (DMKG)
por: Müller, Britta, et al.
Publicado: (2023)

Grey matter changes in medication-overuse headache before and after medication withdrawal
por: Riederer, F, et al.
Publicado: (2013)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

Temperament and character profiles of patients with chronic migraine and medication-overuse headache
por: Watanabe, Y, et al.
Publicado: (2013)

Migraine-specific quality of life questionnaire and relapse of medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2015)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

Effects of smartphone overuse on headache, sleep and quality of life in migraine patients
por: Demir, Yasemin P., et al.
Publicado: (2019)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Theory of Mind in migraine and medication-overuse headache: A cross-sectional study
por: Romozzi, Marina, et al.
Publicado: (2022)

Distinct Food Triggers for Migraine, Medication Overuse Headache and Irritable Bowel Syndrome
por: Ceren Akgor, Merve, et al.
Publicado: (2023)

The impact of COVID-19 pandemic on headache symptoms and drug withdrawal among patients with medication overuse headache: a cross-sectional study
por: Li, Changling, et al.
Publicado: (2021)

Nasal decongestant and chronic headache: a case of naphazoline overuse headache?
por: Di Lorenzo, Cherubino, et al.
Publicado: (2013)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Physical Activity is Associated with Less Analgesic Use in Women Reporting Headache—A Cross-Sectional Study of the German Migraine and Headache Society (DMKG)
por: Müller, Britta, et al.
Publicado: (2022)

Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series
por: Kaltseis, Katharina, et al.
Publicado: (2023)

Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache
por: Gracia-Naya, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9o0ggrm7717cpd8lfj4536c88l